Fresenius SE & Co. KGaA (FSNUF)
OTCMKTS · Delayed Price · Currency is USD
46.21
-1.36 (-2.86%)
At close: Jul 16, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Fresenius Kabi | 8.41B | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Kabi Growth | 5.45% | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Helios | 12.74B | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Helios Growth | 7.01% | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Medical Care | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Medical Care Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate | 373.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Growth | 13.20% | Log In | Log In | Log In | Log In | Upgrade |
Other | 307.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -62.36% | Log In | Log In | Log In | Log In | Upgrade |
Other | 307.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -62.36% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 307.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -62.36% | Log In | Log In | Log In | Log In | Upgrade |
North America | 2.70B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 3.31% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 15.66B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 6.79% | Log In | Log In | Log In | Log In | Upgrade |
Asia-Pacific | 1.60B | Log In | Log In | Log In | Log In | Upgrade |
Asia-Pacific Growth | 0.94% | Log In | Log In | Log In | Log In | Upgrade |
Latin America | 1.40B | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | 16.02% | Log In | Log In | Log In | Log In | Upgrade |
Africa | 156.00M | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | 14.39% | Log In | Log In | Log In | Log In | Upgrade |
Other | 307.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -62.36% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Fresenius Kabi Operating Income | 1.32B | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Kabi Operating Income Growth | 16.13% | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Helios Operating Income | 1.29B | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Helios Operating Income Growth | -4.31% | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Medical Care Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Medical Care Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Income | -118.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Income Growth | 44.44% | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Hospitals | 85.00 | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Hospitals Growth | 0% | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Beds | 30.03K | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Beds Growth | -0.68% | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Hospital Patients | 1.16M | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Hospital Patients Growth | 1.86% | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Outpatient Patients | 4.35M | Log In | Log In | Log In | Log In | Upgrade |
Helios Germany - Number of Outpatient Patients Growth | 2.12% | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed - Order Intake | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed - Order Intake Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed - Order Backlog | - | Log In | Log In | Log In | Log In | Upgrade |
Fresenius Vamed - Order Backlog Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Organic Revenue Growth | 8.00% | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Hospitals | 57.00 | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Hospitals Growth | -1.72% | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Beds | 8.13K | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Beds Growth | -2.31% | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Hospital Patients | 1.17M | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Hospital Patients Growth | 1.57% | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Outpatient Patients | 19.67M | Log In | Log In | Log In | Log In | Upgrade |
Helios Spain - Number of Outpatient Patients Growth | 1.51% | Log In | Log In | Log In | Log In | Upgrade |